Teh-Ying Chou Selected Research

Esophagectomy

2/2014	Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma.
9/2013	The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
4/2011	The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teh-Ying Chou Research Topics

Disease

57	Neoplasms (Cancer) 07/2022 - 11/2003
27	Adenocarcinoma of Lung 01/2022 - 05/2005
23	Lung Neoplasms (Lung Cancer) 07/2022 - 10/2006
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2005
11	Adenocarcinoma 10/2020 - 11/2003
10	Neoplasm Metastasis (Metastasis) 04/2022 - 09/2006
9	Esophageal Squamous Cell Carcinoma 01/2019 - 02/2009
6	Carcinoma (Carcinomatosis) 03/2021 - 11/2003
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020 - 01/2010
3	Carcinogenesis 04/2022 - 04/2002
3	COVID-19 12/2021 - 10/2020
3	Infections 01/2021 - 09/2011
3	Thymoma (Thymic Carcinoma) 08/2012 - 11/2003
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2017
2	Hypoxia (Hypoxemia) 12/2016 - 07/2015
2	Nijmegen Breakage Syndrome 07/2015 - 07/2012
2	Fever (Fevers) 12/2014 - 01/2012
2	Adenomyosis 07/2014 - 11/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 03/2009
2	Colonic Neoplasms (Colon Cancer) 09/2011 - 02/2009
2	Lymphoma (Lymphomas) 09/2009 - 04/2002
1	Inflammation (Inflammations) 03/2021
1	Turcot syndrome 03/2021
1	Signet Ring Cell Carcinoma 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Disease Progression 10/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2018
1	Fibrosis (Cirrhosis) 01/2018

Drug/Important Bio-Agent (IBA)

22	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2005
18	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2006
8	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 05/2005
7	B7-H1 AntigenIBA 07/2022 - 01/2018
7	Tyrosine Kinase InhibitorsIBA 01/2018 - 05/2005
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2012
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2006
4	Cadherins (E-Cadherin)IBA 01/2021 - 05/2009
4	CytokinesIBA 01/2021 - 01/2012
4	AntibodiesIBA 10/2020 - 10/2006
4	Mitochondrial DNA (mtDNA)IBA 01/2019 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2021 - 04/2016
3	PlatinumIBA 04/2016 - 05/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013 - 02/2012
3	Gefitinib (Iressa)FDA Link 06/2011 - 05/2005
2	Serine (L-Serine)FDA Link 01/2022 - 07/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Actin Depolymerizing Factors (Cofilins)IBA 02/2021 - 05/2011
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 09/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 09/2009
2	Nucleic AcidsIBA 10/2020 - 11/2016
2	Indicators and Reagents (Reagents)IBA 10/2020 - 09/2006
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2020 - 10/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2012
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2015
2	Histone Deacetylase InhibitorsIBA 04/2015 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 01/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2013 - 05/2005
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012 - 08/2010
2	Small Interfering RNA (siRNA)IBA 08/2012 - 05/2009
2	Vinorelbine (Navelbine)FDA LinkGeneric 02/2012 - 05/2007
2	ParaffinIBA 06/2011 - 05/2005
2	Prostaglandin-E SynthasesIBA 08/2010 - 09/2006
1	Forkhead Box Protein M1IBA 04/2022
1	Centrosomal Associated ProteinsIBA 04/2022
1	ProteomeIBA 01/2022
1	Semaphorin-3AIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 12/2021
1	CateninsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Interferon LambdaIBA 01/2021
1	InterferonsIBA 01/2021
1	Poly I-CIBA 01/2021
1	Immunoglobulin M (IgM)IBA 10/2020
1	Immunoglobulin G (IgG)IBA 10/2020
1	Polymethyl Methacrylate (Sol)IBA 10/2020
1	SmokeIBA 09/2020
1	Nicotine FDA Link 09/2020
1	osimertinibIBA 09/2020
1	Prion ProteinsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Thyroid Nuclear Factor 1IBA 01/2019
1	Threonine (L-Threonine)FDA Link 07/2018
1	AcetylglucosamineIBA 07/2018
1	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 07/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	LectinsIBA 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 11/2004
12	Drug Therapy (Chemotherapy) 03/2021 - 05/2007
6	Adjuvant Chemotherapy 07/2020 - 09/2013
4	Immunotherapy 01/2022 - 01/2018
3	Radiotherapy 04/2015 - 06/2008
3	Esophagectomy 02/2014 - 04/2011
2	Neoadjuvant Therapy 01/2020 - 09/2013
2	Thoracotomy 01/2018 - 11/2013
2	Hematopoietic Stem Cell Transplantation 01/2012 - 12/2011
1	Chemoradiotherapy 06/2017